rgx-104
Showing 1 - 1 of 1
Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)
Recruiting
- Endometrial Cancer
- +5 more
- RGX-104
- +6 more
-
Los Angeles, California
- +13 more
Jul 21, 2022